Filing Flows

Filing Flows › Korro Bio (KRRO) › Next earnings date

Korro Bio (KRRO) earnings: beat the estimate

Korro Bio (KRRO) reported on Nov 5, 2026 and beat the EPS estimate: −$0.98 against −$1.26 (+22.3%). It beat the EPS estimate in 100% of the quarters on record.

Last result+22.3% vs estimate
Beat rate100%

The last report

Korro Bio reported revenue of $1.3M for the fourth quarter 2025 (-43% Y/Y), net loss $50.0M. How it makes money → · Every quarter →

Korro Bio: EPS against the estimate, last 5 reportsKorro Bio: EPS against the estimate, last 5 reportsEstimateReported−$2.68−$1.92Nov 25−$2.14−$1.65Mar 26−$1.98−$1.69May 26−$1.28−$1.07Aug 26−$1.26−$0.98Nov 26
Latest (Nov 26): Estimate −$1.26, Reported −$0.98.

Korro Bio's latest quarter

Korro Bio, Q4 2025: revenue $1.3M (-43% year over year), net loss $50.0M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did Korro Bio beat earnings?

Korro Bio (KRRO) reported on Nov 5, 2026 and beat the EPS estimate: −$0.98 against −$1.26 (+22.3%).

When does KRRO report earnings?

The next date is not set yet.

Does Korro Bio usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.